A new trading day began on Friday, with Procept BioRobotics Corp (NASDAQ: PRCT) stock price up 3.66% from the previous day of trading, before settling in for the closing price of $40.12. PRCT’s price has ranged from $37.12 to $103.81 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -12.56%. Meanwhile, its annual earnings per share averaged 15.14%. With a float of $52.89 million, this company’s outstanding shares have now reached $55.58 million.
Let’s determine the extent of company efficiency that accounts for 756 employees. In terms of profitability, gross margin is 64.19%, operating margin of -33.37%, and the pretax margin is -30.6%.
Procept BioRobotics Corp (PRCT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Procept BioRobotics Corp is 4.93%, while institutional ownership is 96.28%. The most recent insider transaction that took place on Aug 13 ’25, was worth 785,138. In this transaction Director of this company bought 20,000 shares at a rate of $39.26, taking the stock ownership to the 863,159 shares. Before that another transaction happened on Jun 10 ’25, when Company’s Director sold 25,000 for $63.91, making the entire transaction worth $1,597,711. This insider now owns 64,363 shares in total.
Procept BioRobotics Corp (PRCT) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.4 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 36.69% during the next five years compared to -12.56% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Here are Procept BioRobotics Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Looking closely at Procept BioRobotics Corp (NASDAQ: PRCT), its last 5-days average volume was 1.37 million, which is a jump from its year-to-date volume of 1.03 million. As of the previous 9 days, the stock’s Stochastic %D was 26.50%.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 15.04%, which indicates a significant decrease from 24.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.64 in the past 14 days, which was lower than the 2.81 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $54.97, while its 200-day Moving Average is $67.18. However, in the short run, Procept BioRobotics Corp’s stock first resistance to watch stands at $42.64. Second resistance stands at $43.69. The third major resistance level sits at $44.68. If the price goes on to break the first support level at $40.60, it is likely to go to the next support level at $39.62. Now, if the price goes above the second support level, the third support stands at $38.57.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
With a market capitalization of 2.31 billion, the company has a total of 55,636K Shares Outstanding. Currently, annual sales are 224,500 K while annual income is -91,410 K. The company’s previous quarter sales were 79,180 K while its latest quarter income was -19,580 K.
